The Social Health Authority (SHA) headquarters in Nairobi.




Kenyans seeking funding for specialised treatment abroad will now follow a tightly controlled process devised by the Social Health Authority (SHA). 
Enjoying this article? Subscribe for unlimited access to premium sports coverage.
View Plans
SHA CEO Dr Mercy Mwangangi said the overseas treatment package, which opens on April 14, is designed to correct weaknesses that existed under the defunct NHIF, where patients were often referred abroad without proper vetting of hospitals, costs or necessity.

Only 36 procedures -deemed unavailable in Kenya - now qualify for overseas funding. Patients must be referred by a doctor, vetted by regulators, and approved by the SHA before travel. The authority will cover up to Sh500,000 per patient per year, with patients meeting any additional costs.

 “We have followed the law, activated expert panels, and determined the procedures that Kenyans can only access overseas,” Dr Mwangangi told The Star Health.

Below is the official list of services that can be funded by SHA abroad, as published in the Kenya Gazette in September 2025, with simplified explanations and SHA's justification.

1. Wrist joint arthroplasty

Replacement of a damaged wrist joint with an artificial implant to restore movement, stability and reduce chronic pain. Justification: Lack of dedicated joint replacement and implant availability in Kenya.

2. Metacarpal joint arthroplasty

Replacement of small joints in the hand to improve finger movement, function and relieve severe joint damage. Justification: Limited access to prostheses and expertise in Kenya.

3. Ankle joint arthroplasty

Surgical replacement of the ankle joint to restore mobility and relieve pain caused by arthritis or injury. Justification: Lack of surgical expertise and advanced implants in Kenya.

4. Whole femoral replacement

Complete replacement of the thigh bone using a large artificial implant, often for severe trauma or bone cancer cases. Justification: No access to mega-prostheses locally.

5. Proximal femoral replacement

Replacement of the upper part of the thigh bone near the hip to treat tumours or severe bone damage. Justification: Inadequate oncology infrastructure locally.

6. Distal femoral replacement

Replacement of the lower part of the thigh bone near the knee to restore function after major bone loss or disease. Justification: Lack of implants and training locally.

7. Proximal tibial replacement

Replacement of the upper part of the shin bone to manage bone tumours or complex fractures affecting the knee joint. Justification: Not routinely performed due to resource limitations

8. Allograft use

Use of donated human bone tissue to reconstruct or replace damaged bone during complex surgical procedures. Justification: No national bone bank

9. Complex congenital heart surgery requiring ECMO in paediatrics

Highly specialised heart surgery in children supported by machines that temporarily take over heart and lung function. Justification: Lack of ECMO capacity and ICU support

10. Liver transplant

Surgical replacement of a failing liver with a healthy donor organ to save patients with severe liver disease. Justification: No paediatric liver transplant programme

11. Bone marrow transplant

Procedure that replaces damaged bone marrow with healthy cells to treat cancers and blood disorders. Justification: No dedicated bone marrow transplant units

12. Kidney transplant (paediatric)

Transplantation of a kidney into a child to treat advanced kidney failure and restore normal body function. Justification: Underdeveloped paediatric nephrology services

13. Intrathecal chemotherapy for retinoblastoma

Direct delivery of cancer drugs into the spinal fluid to treat advanced eye cancer in children. Justification: Limited access to specialist paediatric oncology

14. Laryngeal transplant

Replacement of the voice box to restore breathing, speech and swallowing functions in severe cases. Justification: No national legal framework for larynx transplantation

15. Intrauterine blood transfusion

Procedure where blood is transfused directly to an unborn baby to treat severe anaemia before birth. Justification: Lack of foetal therapy centres and specialists

16. Intrauterine shunt placement (bladder obstruction, hydrothorax, cysts)

Insertion of tiny tubes in the womb to drain excess fluid and relieve pressure in the unborn baby. Justification: No capacity for intrauterine surgical procedures

17. Intrauterine vesicocentesis, thoracentesis, paracentesis

Needle procedures performed in the womb to remove abnormal fluid from the foetus for treatment or diagnosis. Justification: Lack of interventional radiology in maternal-foetal care

18. Fetoscopy, amniotic band ligation, laser ablation

Minimally invasive surgeries performed inside the womb to correct life-threatening foetal conditions. Justification: Absence of specialised instruments and trained personnel

19. Amnioreduction, amnioinfusion

Procedures that remove or add amniotic fluid to manage pregnancy complications affecting the baby. Justification: Rarely performed due to risk and limited technical skills

20. Foetal reduction, cord occlusion, cordocentesis

Specialised procedures to manage high-risk multiple pregnancies or diagnose and treat foetal conditions. Justification: Lack of tools and protocols

21. Advanced endometriosis excision

Complex surgery to remove deeply embedded endometriosis tissue causing severe pain and fertility issues. Justification: Limited advanced laparoscopic skills

22. Sacral neuromodulation for urinary/faecal incontinence

Use of implanted devices to send electrical signals that help control bladder or bowel function. Justification: No equipment or trained urogynecologists

23. Peptide Receptor Radionuclide Therapy (PRRT) – Lutetium-177

Targeted cancer treatment using radioactive substances that bind to tumour cells and destroy them. Justification: Lack of nuclear medicine infrastructure

24. DOTA-TATE PET/CT scan

Advanced imaging scan used to detect and monitor specific types of tumours with high precision. Justification: Diagnostic service not available

25. Fibroblast Activation Protein Inhibitor (FAPI) PET/CT imaging

Highly specialised scan that detects cancer and fibrotic diseases by targeting specific cellular activity. Justification: Not available nationally

26. Microwave ablation of metastatic tumours

Minimally invasive procedure that uses heat generated by microwaves to destroy cancerous tumours. Justification: No national capacity

27. CAR T-cell therapy

Advanced treatment where a patient’s immune cells are genetically modified to identify and attack cancer cells. Justification: Highly specialised and not available

28. Bispecific T-cell engagers

Engineered drugs that direct the immune system to attack cancer cells by binding two targets at once. Justification: No regulatory pathway or production

29. Allogeneic bone marrow/peripheral stem cell transplant

Transplant of blood-forming stem cells from a donor to treat serious blood cancers and disorders. Justification: Capacity limited; only autologous transplants available

30. Transjugular intrahepatic portosystemic shunt (TIPS)

Procedure that creates a pathway in the liver to reduce pressure and prevent complications of liver disease. Justification: Lack of essential tools and consumables

31. Yttrium-90 (Y-90) radioembolisation

Treatment that delivers radioactive particles directly into liver tumours to shrink or destroy them. Justification: No access to isotopes and delivery systems

32. Surgical management of birth-related brachial plexus injuries

Surgery to repair nerve damage in newborns affecting arm movement due to birth complications. Justification: Lack of equipment and trained personnel

33. Photopheresis (Extracorporeal photopheresis)

A blood treatment that uses light-activated drugs to modify immune cells in certain diseases. Justification: Not available

34. Nerve ablation therapy

Procedure that destroys specific nerves to relieve chronic pain or control abnormal nerve activity. Justification: Lack of neurophysiology equipment and personnel

35. Neural regenerative therapy

Emerging treatments aimed at repairing or regrowing damaged nerve tissues to restore function. Justification: Lack of neurophysiology equipment and personnel.

36. Proton therapy

Highly precise form of radiation therapy that targets tumours while minimising damage to surrounding tissues. Justification: Not available in Kenya.